| Item type: | Article | ||||
|---|---|---|---|---|---|
| Journal or Publication Title: | Urologic Oncology: Seminars and Original Investigations | ||||
| Publisher: | ELSEVIER SCIENCE INC | ||||
| Place of Publication: | NEW YORK | ||||
| Volume: | 41 | ||||
| Number of Issue or Book Chapter: | 5 | ||||
| Page Range: | 254.e1-254.e8 | ||||
| Date: | 2023 | ||||
| Institutions: | Medicine > Lehrstuhl für Urologie | ||||
| Identification Number: |
| ||||
| Keywords: | BLADDER-CANCER; MICROSCOPIC HEMATURIA; RISK; ASSOCIATION; MANAGEMENT; ADULTS; CARE; MEN; AUA; Bladder cancer; Disease management; Guidelines; Microhematuria; Nomogram; Risk factors | ||||
| Dewey Decimal Classification: | 600 Technology > 610 Medical sciences Medicine | ||||
| Status: | Published | ||||
| Refereed: | Yes, this version has been refereed | ||||
| Created at the University of Regensburg: | Yes | ||||
| Item ID: | 76054 |
Web of ScienceAbstract
Background & Objective: Asymptomatic microhematuria (aMh) remains a diagnostic challenge in urological practice: while aMh is a risk factor of urothelial carcinoma (UC), prevalence of aMh is high. Guidelines were developed to permit risk stratification and reduce diag-nostic workload. This study investigates the efficacy of several recommendations.Material & Methods: Sixty hundred eight patients ...
Abstract
Background & Objective: Asymptomatic microhematuria (aMh) remains a diagnostic challenge in urological practice: while aMh is a risk factor of urothelial carcinoma (UC), prevalence of aMh is high. Guidelines were developed to permit risk stratification and reduce diag-nostic workload. This study investigates the efficacy of several recommendations.Material & Methods: Sixty hundred eight patients with newly diagnosed aMh without previous UC from an academic referral center (A; n = 320) and a private outpatient clinic (B; n = 288) were included. All patients underwent clinical workup including medical history, urine cytology, upper tract imaging and cystoscopy. Eleven former and current guidelines were applied to each patient individually; every patient was classified as either low risk (no further workup recommended) or high risk. Furthermore, a recently developed nomogram for hematuria assessment was included. Results: The cohort comprised 142 females and 466 males (mean age 62 [range 18-92] years). Sixty-one patients (10.0%) were diagnosed with UC. Excluding the Swedish and recent NICE guideline generally advising against urologic workup, application of 9 other recommendations would have diagnosed all UCs and saved 1.6% to 16.1% of patients from workup. For the 2020 US guideline, solely applied to cohort B, 10.6% of patients were classified as low risk. The use of the nomogram would have saved 17.1% to 25% of patients from workup.Conclusions: Practical relevance of current guidelines is limited as they do not sufficiently identify patients not requiring clinical work up. Thus, guideline adherence may trigger overdiagnosis and even overtreatment. New ways of risk stratification are needed to improve aMh assessment.& COPY; 2022 Elsevier Inc. All rights reserved.
Metadata last modified: 18 Mar 2025 10:08
Altmetric